Evaluation of 8-hydroxydeoxyguanosine, thiobarbituric acid-reactive substances and total antioxidant status as possible disease markers in oesophageal malignancies

Clinical Biochemistry

Volumn 41, Issue 10-11, 2008, Pages 796-803

  Diakowska, Dorota ^a   Krzystek Korpacka, Malgorzata ^a   Lewandowski, Andrzej ^a   Grabowski, Krzysztof ^a   Diakowski, Witold ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

DNA damage; Oesophageal squamous cell carcinoma (OSCC); Oxidative stress; Thiobarbituric acid reactive substances (TBARS); Total antioxidant status (TAS); Tumour marker

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS DISEASE; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; DEOXYGUANOSINE; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR MARKERS, BIOLOGICAL;

EID: 44949102148     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.03.014     Document Type: Article

References (39)

1. Jemal A., Murray T., Ward E., et al. Cancer Statistics. CA Cancer J Clin 55 (2005) 10-30
2. Tew W.S., Kelsen D., and Ilson D. Targeted therapies for oesophageal cancer. Oncologist 10 (2005) 590-601
3. Messmann H. Squamous cell cancer of the oesophagus. Best Pract Res Clin Gastroenterol 15 (2001) 249-265
4. Enzinger P.C., and Mayer R.J. Esophageal cancer. N Engl J Med 349 (2003) 2241-2252
5. Orzechowski A. Possible implications of redox-sensitive tumour cell transformation; lessons from cell culture studies. Pol J Vet Sci 10 (2007) 123-126
6. Laviano A., Meguid M.M., Preziosa I., et al. Oxidative stress and wasting in cancer. Curr Opin Clin Nutr Metab Care 10 (2007) 449-456
7. Valko M., Rhodes C.J., Moncol J., et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160 (2006) 1-40
8. Diakowska D., Lewandowski A., Kopec W., et al. Oxidative DNA damage and total antioxidant status in serum of the patients with esophageal squamous cell carcinoma. Hepato-Gastroenterology 54 (2007) 1700-1703
9. Diakowska D., Grabowski K., Nienartowicz M., et al. Lipid peroxidation and total antioxidant status in upper gastrointestinal tract cancers. Gastroenterol Pol 14 (2007) 405-408
10. Sobin L.H., and Wittekind C.H. TNM Classification of Malignant Tumors. 6th ed. (2002), Jon Wiley & Sons, Hoeboken, New Jersey
11. Bartosz G. Druga twarz tlenu. Wolne rodniki w przyrodzie. (The other face of oxygen. Free radicals in the environment). 2nd ed (2004), Wydawnictwo Naukowe PWN, Warszawa
12. Pepe M.S., Janes H., Longton G., et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159 (2004) 882-890
13. Pelucchi C., Gallus S., Garavello W., et al. Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Res Health 29 (2006) 193-198
14. Valko M., Leibfritz D., Moncol J., et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39 (2007) 44-84
15. Seitz HK, Becker P. Alcohol metabolism and cancer risk. Alcohol Res Health 2007;30:38-41,44-47.
16. Chen J., Yan Y., Li J., et al. Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells. Carcinogenesis 26 (2005) 1035-1043
17. Stoner G.D., Wang L.S., and Chen T. Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol 224 (2007) 337-349
18. Azad N., Rojanasakul Y., and Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 11 (2008) 1-15
19. Hwang E.S., and Kim G.H. Biomarkers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology 229 (2007) 1-10
20. Bonde P., Gao D., Chen L., et al. Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus. J Thorac Cardiovasc Surg 133 (2007) 74-81
21. Chen X., Ding Y.W., Yang G., et al. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 21 (2000) 257-263
22. Li Y., Wo J.M., Su R.R., Ray M.B., and Martin R.C. Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann Surg Oncol 14 (2007) 2045-2055
23. Lerut T., Coosemans W., Decker G., et al. Surgical techniques. J Surg Oncol 92 (2005) 218-229
24. Dursun H., Bilici M., Uyanik A., et al. Antioxidant enzyme activities and lipid peroxidation levels in erythrocytes of patients with oesophageal and gastric cancer. J Int Med Res 34 (2006) 193-199
25. Martin R.C., Liu Q., Wo J.M., et al. Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation. Clin Cancer Res 13 (2007) 5176-5182
26. Calişkan-Can E., Firat H., Ardiç S., et al. Increased levels of 8-hydroxydeoxyguanosine and its relationship with lipid peroxidation and antioxidant vitamins in lung cancer. Clin Chem Lab Med 46 (2008) 107-112
27. Lapenna D., Ciofani G., Pierdomenico S.D., et al. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 31 (2001) 331-335
28. Bartsch H., and Nair J. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect Prev 28 (2004) 385-391
29. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
30. Mealy K., Feely J., Reid I., et al. Tumour marker detection in oesophageal carcinoma. Eur J Surg Oncol 22 (1996) 505-507
31. Shimada H., Nabeya Y., Tagawa M., et al. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Cancer Sci 94 (2003) 628-632
32. Shimada H., Nabeya Y., Okazami S., et al. Prediction of survival with squamous cel carcinoma antigen in patients with respectable esophageal squamous cell carcinoma. Surgery 133 (2003) 486-494
33. Kosugi S., Nishimaki T., Kanda T., et al. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg 28 (2004) 680-685
34. Shimada Y., Watanabe G., Kawamura J., et al. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers. Oncology 68 (2005) 285-292
35. Tomita H., Ichikawa D., Ikoma D., et al. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer. Anticancer Res 27 (2007) 2737-2741
36. Mroczko B., Kozłowski M., Groblewska M., et al. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squmous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Clin Chim Acta 389 (2008) 61-66
37. Krzystek-Korpacka M., Matusiewicz M., Diakowska D., et al. Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Lett 249 (2007) 171-177
38. Krzystek-Korpacka M., Matusiewicz M., Diakowska D., et al. Elevation of circulating interleukin 8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas - implication for clinical evaluation of cancer patient. Cytokine 41 (2008) 232-239
39. Krzystek-Korpacka M., Matusiewicz M., Diakowska D., et al. Serum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinoma. Biomarkers 12 (2007) 403-413